Tofacitinib in a case of generalized granuloma annulare: A two-year follow-up of relapse and remission

Recent research into the immunopathogenesis of granuloma annulare (GA) has led to new treatments.We share our experience with tofacitinib, a Janus Kinase/signal transducer and activator of transcription (JAK/STAT) inhibitor, in a biopsy-proven case of generalized GA (GGA) over two years of follow-up.www.cosmoderma.org

Authors

Publication Details

Journal
Cosmoderma
Published
2024-09-30
DOI
https://doi.org/10.25259/csdm_137_2024
Primary Topic
Skin Diseases and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tofacitinib in a case of generalized granuloma annulare: A two-year follow-up of relapse and remission

Shruthi Pavana Janardhanan, Punit Saraogi
Cosmoderma
Skin Diseases and Diabetes
article

Tofacitinib in a case of generalized granuloma annulare: A two-year follow-up of relapse and remission

Shruthi Pavana Janardhanan, Punit Saraogi
article en

Abstract

Recent research into the immunopathogenesis of granuloma annulare (GA) has led to new treatments.We share our experience with tofacitinib, a Janus Kinase/signal transducer and activator of transcription (JAK/STAT) inhibitor, in a biopsy-proven case of generalized GA (GGA) over two years of follow-up.www.cosmoderma.org

CosmodermaVol. 4
Zero hunger
Openalex Percentile: Top 65%
Skin Diseases and Diabetes
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Tofacitinib in a case of generalized granuloma annulare: A two-year follow-up of relapse and remission — Shruthi Pavana Janardhanan, Punit Saraogi · Cosmoderma (2024) | TGRS Research Map | TGRS